Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in childrenAya Inaba, Masataka Honda, Yuko Hamasaki et al.|Pediatric Nephrology|2015Cited by 37
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)Kandai Nozu, Kazumoto Iijima, Seiji Tanaka et al.|Clinical and Experimental Nephrology|2023Cited by 6
Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up studyKazumoto Iijima, Yosuke Inaguma, Mayumi Sako et al.|Scientific Reports|2025Cited by 5
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children: response to commentsAya Inaba, Tetsuji Kaneko, Yuko Hamasaki et al.|Pediatric Nephrology|2015Cited by 3
A digest of the clinical practice guideline for pediatric idiopathic nephrotic syndrome 2020 updated: medical therapyRiku Hamada, Kenji Ishikura, Yoshitsugu Kaku et al.|Clinical and Experimental Nephrology|2025Cited by 2